The most notable market participants are B. Braun SE, Becton Dickinson and Co, Nipro Corp, Cardinal Health Inc, Medline Industries Inc, Terumo Corp, SB-Kawasumi Laboratories Inc, and ICU Medical Inc among others occupying a considerable share of the market owing to their offerings to the market.

Market leaders are involved in extensive research for the development of new MENAT Butterfly Needle with better efficiency and treatment outcomes. For instance, in January 2022, ICU Medical Inc. announced that it has completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products.

Many well-known as well as small local companies are present in the market to provide diversified products to its customers. The larger firms are adopting the strategy of acquiring small firms to enhance its product portfolio and expand its footprint in different geographies. Additionally, various companies are also undergoing other strategic alliances such as collaborations and others to garner their significance and remain competitive in the market.

Read more: https://www.theinsightpartners.com/reports/meant-butterfly-needles-market